Price: 4.69

Today's Change: -0.01

Today's Percent Change: 0.87%

Today's Volume: 12360

Average Daily Volume: 49402

52 week low: 2.82

52 week high: 6.07

Market cap: 77830000.0

EBITDA: -9570000.0

EBITDA / market_cap: -12.30%

Earnings per Share (EPS): -0.56

EPS / price: -11.94%

Dividend Yield: 0.0%

Dividend per share: 0.0

Book value: 1.49

Price to Book Ratio: 3.16

Price to Earnings (P/E) Ratio: 0.0

Price to Earnings Growth (PEG) Ratio: -0.58

Price to Sales (P/S) Ratio: 2.98

Short Ratio: 2.22

Exchange: "NCM"

Short term: DOWN (Previous: DOWN)

Mid term: DOWN (Previous: DOWN)

Long term: UP (Previous: UP)

Support: 4.91

Resistance: 5.03

Pivot point: 4.97

SMA 10: 5.10

SMA 50: 4.85

SMA 100: 4.22

RSI 10: 43.42

RSI 50: 53.01

RSI 100: 52.11

EMA 10: 5.14

EMA 50: 4.70

EMA 100: 4.02

HOLD

Based on 4 buy signals and 8 sell signals

Previous signal: hold

3.64

NEGATIVE

ICAD
ICAD

@dispatchtribune: Q2 2019 EPS Estimates for iCAD Inc $ICAD Lowered by Zacks Investment Research https://t.co/evXzOez9SG

@smallcapwatch: RT @AnalystsAnalyst: $ICAD Therapy Buoys Q1 Sales, Benefits Operating Loss https://t.co/zVpK2o7juU $ICAD #biotech #medtech #smallcap https:…

@AnalystsAnalyst: $ICAD Therapy Buoys Q1 Sales, Benefits Operating Loss https://t.co/zVpK2o7juU $ICAD #biotech #medtech #smallcap https://t.co/otmyfhJWit

@bulletin_en: Comparing of Varonis Systems Inc. $ICAD https://t.co/ueGiB35ypb

@WeekHerald: Zacks Investment Research Comments on iCAD Inc’s Q2 2019 Earnings $ICAD https://t.co/fz3nu8eOVR

@bulletin_en: iCAD, Inc. $ICAD Forms $5.55 Double Top; Chipotle Mexican Grill, Inc. $CMG Covered By 6 Bullish Analysts Last Week https://t.co/kDGWltcIaz

@RatingsNetwork: Zacks Investment Research Lowers iCAD Q2 2019 Earnings Estimates to ($0.10) EPS (Previously ($0.09)). https://t.co/AHafZPUqY8 $ICAD #ICAD

@ThisLincolnian: FY2020 EPS Estimates for iCAD Inc Raised by Zacks Investment Research $ICAD https://t.co/oW8lKwv7Bk

@smallcapwatch: RT @ContentCarnivor: $ICAD Therapy Buoys Q1 Sales, Benefits Operating Loss https://t.co/9ZhRPXunNy $ICAD #biotech #medtech #smallcap https:…

@ContentCarnivor: $ICAD Therapy Buoys Q1 Sales, Benefits Operating Loss https://t.co/9ZhRPXunNy $ICAD #biotech #medtech #smallcap https://t.co/PbtLqXivJn

@RatingsNetwork: Zacks Investment Research Raises iCAD FY2020 Earnings Estimates to $0.05 EPS (Previously $0.03). https://t.co/xy6KN64ufy $ICAD #ICAD

@dailypoliticaln: Pro-Dex $PDEX vs. iCAD $ICAD Critical Review https://t.co/gWtqc7V3vk

@fallondpicks: 7 #breakouts: $ARE, $DOX (gap and 200-day MA), $ICAD. There are four plays currently active for https://t.co/KYzI8pHGhj

@fm23: $ICAD https://t.co/QNtFYfroJS